SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001062993-18-002649
Filing Date
2018-06-19
Accepted
2018-06-18 18:08:02
Documents
2
Group Members
CTI LIFE SCIENCES FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D sched13d.htm SC 13D 50239
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 3260
  Complete submission text file 0001062993-18-002649.txt   55099
Mailing Address 1344 SUMMER STREET, SUITE 412 HALIFAX A5 B3H 0A8
Business Address 1344 SUMMER STREET, SUITE 412 HALIFAX A5 B3H 0A8 9024921819
IMV Inc. (Subject) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2Q | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90518 | Film No.: 18905612
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 PLACE VILLE - MARIE, SUITE 1050 MONTREAL A8 H3B 4S6
Business Address 1 PLACE VILLE - MARIE, SUITE 1050 MONTREAL A8 H3B 4S6 5147982333X229
CTI Partners II, L.P. (Filed by) CIK: 0001743924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13D